NYSE - Delayed Quote USD

ResMed Inc. (RMD)

216.98 -1.17 (-0.54%)
At close: May 3 at 4:00 PM EDT
215.05 -1.93 (-0.89%)
After hours: May 3 at 7:50 PM EDT
Loading Chart for RMD
DELL
  • Previous Close 218.15
  • Open 219.63
  • Bid 217.30 x 800
  • Ask 217.40 x 900
  • Day's Range 216.72 - 221.40
  • 52 Week Range 132.24 - 237.26
  • Volume 629,682
  • Avg. Volume 1,115,404
  • Market Cap (intraday) 31.876B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 33.33
  • EPS (TTM) 6.51
  • Earnings Date Aug 1, 2024 - Aug 5, 2024
  • Forward Dividend & Yield 1.92 (0.88%)
  • Ex-Dividend Date May 8, 2024
  • 1y Target Est 212.34

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

www.resmed.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMD

Performance Overview: RMD

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RMD
26.45%
S&P 500
7.50%

1-Year Return

RMD
7.09%
S&P 500
24.47%

3-Year Return

RMD
18.37%
S&P 500
22.64%

5-Year Return

RMD
114.53%
S&P 500
75.76%

Compare To: RMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMD

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    31.88B

  • Enterprise Value

    32.81B

  • Trailing P/E

    33.38

  • Forward P/E

    25.77

  • PEG Ratio (5yr expected)

    1.91

  • Price/Sales (ttm)

    6.98

  • Price/Book (mrq)

    6.88

  • Enterprise Value/Revenue

    7.16

  • Enterprise Value/EBITDA

    21.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.91%

  • Return on Assets (ttm)

    11.91%

  • Return on Equity (ttm)

    22.39%

  • Revenue (ttm)

    4.58B

  • Net Income Avi to Common (ttm)

    958.38M

  • Diluted EPS (ttm)

    6.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    259.45M

  • Total Debt/Equity (mrq)

    25.21%

  • Levered Free Cash Flow (ttm)

    955.85M

Research Analysis: RMD

Company Insights: RMD

Research Reports: RMD

People Also Watch